Sexual Health Treatment. Private. Fast. Judgment-Free.
Doctor-prescribed STD and sexual health medications delivered discreetly to your door.
Physicians
Private
Delivery
DoxyPep 100mg
Post-exposure prophylaxis to help prevent bacterial STIs.
- Take Within 72 Hours
- Cuts Bacterial STI Risk
- Simple As-Needed Dose
Metronidazole 500mg
Antibiotic for bacterial vaginosis and trichomoniasis.
- Treats BV & Trich
- Proven Antibiotic
- Short Treatment Course
Valacyclovir 500mg
Antiviral that controls and suppresses herpes outbreaks.
- Controls Outbreaks
- Daily Suppression Option
- Reduces Transmission
If you typed "doxycycline for gonorrhea" into a search bar, you’re probably looking for a straight answer: can this old, cheap antibiotic still clear the infection in 2026, or is it now useless? The honest answer is more interesting than yes or no.
Doxycycline hasn’t been a first-line treatment for gonorrhea in the United States for years. But it’s quietly become important again, just not in the way most people assume. There’s a real role for it. There’s also a real risk in using it wrong.
What I tell patients is this: the drug still matters, but where it fits in the treatment plan has shifted significantly, and the CDC’s 2021 STI Treatment Guidelines (still the operative document going into 2026) lay out exactly why.
Why Doxycycline Isn’t First-Line Anymore
Gonorrhea has been outsmarting antibiotics for almost a century. Penicillin, tetracyclines, fluoroquinolones, oral cephalosporins. One by one, Neisseria gonorrhoeae found a way around them.
By the early 2000s, resistance to tetracyclines (the class doxycycline belongs to) was widespread enough that the CDC stopped recommending it for gonorrhea monotherapy. Surveillance data from the Gonococcal Isolate Surveillance Project has consistently shown tetracycline resistance rates above 25% in US isolates, and in some years closer to 45%.
That’s a deal-breaker. You can’t use a drug to treat a bacterial infection when one in three or four strains are already resistant before you start. So using doxycycline for gonorrhea as a stand-alone cure isn’t appropriate in 2026, and hasn’t been for a long time.
So What Is the First-Line Treatment in 2026?
For uncomplicated gonorrhea of the cervix, urethra, or rectum, the current standard is a single intramuscular dose of ceftriaxone. The dose was bumped up to 500 mg in 2020 (1 g if you weigh 150 kg or more) specifically because of creeping resistance concerns.
Notably, the CDC no longer recommends adding azithromycin as a routine partner drug. That changed in 2020 too, largely because azithromycin resistance was climbing faster than anyone wanted.
If you’re curious about how the older two-drug approach compared to current practice, this breakdown of azithromycin versus doxycycline for gonorrhea walks through the head-to-head differences and why neither is the answer on its own.
Where Doxycycline for Gonorrhea Still Fits
Here’s where it gets interesting. Doxycycline still shows up in three specific situations:
- Co-treating chlamydia. A huge percentage of patients diagnosed with gonorrhea also test positive for chlamydia. Standard practice is to give ceftriaxone for the gonorrhea and a 7-day course of doxycycline (100 mg twice daily) for the chlamydia, assuming chlamydia hasn’t been ruled out.
- Cephalosporin allergy. For patients who can’t take ceftriaxone, alternative regimens sometimes include doxycycline as part of a combination, though gentamicin plus azithromycin is more commonly used now.
- Doxy-PEP (post-exposure prophylaxis). This is the big shift. In 2023, the CDC issued draft guidelines, finalized into broader practice through 2024 and 2025, recommending 200 mg of doxycycline taken within 72 hours of condomless sex for certain high-risk groups (primarily men who have sex with men and transgender women with a recent bacterial STI). The NEJM DoxyPEP trial showed roughly a two-thirds reduction in chlamydia and syphilis, with a more modest effect on gonorrhea.
So doxycycline for gonorrhea, in the prevention sense, has a real (if imperfect) role. As a cure on its own, it doesn’t.
What About Treating Gonorrhea If You Can’t Get Ceftriaxone?
This comes up. Maybe you’re traveling, maybe the clinic is closed, maybe you have a severe beta-lactam allergy. The temptation to grab leftover doxycycline is real.
Don’t. Here’s why:
- Resistance rates make cure unreliable.
- Untreated or partially treated gonorrhea can lead to pelvic inflammatory disease, infertility, epididymitis, and disseminated infection.
- Partial treatment may actually breed more resistance, both in you and in the broader community.
If ceftriaxone genuinely isn’t accessible, the appropriate move is to call a prescriber or go to an urgent care or sexual health clinic. Many state and county health departments offer free or low-cost STI treatment, and ceftriaxone is widely available. Compare prices on doxycycline and related antibiotics at edrugstore.com if your prescriber has determined it’s the right fit for your situation, but the gonorrhea piece itself needs the injection.
Side Effects and Practical Notes on Doxycycline
If you’re prescribed doxycycline as part of a combination regimen, a few practical things worth knowing:
- Take it with a full glass of water, sitting upright, ideally not right before bed. Pill esophagitis is unpleasant and common with doxycycline.
- Skin photosensitivity is real. Wear sunscreen.
- Avoid taking it within two hours of dairy, antacids, iron, or calcium supplements. They bind the drug and reduce absorption.
- Nausea is the most common GI complaint. Taking it with a small amount of food (just not dairy) usually helps.
For comparison, other antiviral STI regimens like valacyclovir versus acyclovir for herpes have a very different side effect profile and dosing logic, which is worth knowing if you’re being treated for more than one infection at once.
When to Follow Up After Treatment
Test-of-cure isn’t routinely recommended for uncomplicated urogenital gonorrhea treated with ceftriaxone, but it is recommended for pharyngeal infections (the throat is harder to clear). MedlinePlus’s gonorrhea page is a useful patient-level summary if you want a second source.
Re-testing at three months, on the other hand, is recommended for everyone, because reinfection rates are high.
Call your prescriber if:
- Symptoms haven’t improved within a week
- You develop joint pain, rash, or fever
- You had pharyngeal exposure and weren’t tested for that site
- A recent partner hasn’t been treated
The Bottom Line
Doxycycline for gonorrhea, used alone, isn’t reliable treatment in 2026, and it hasn’t been for years. Ceftriaxone is the standard. Doxycycline still earns its place as part of combination therapy when chlamydia is also in the picture, and as doxy-PEP for selected high-risk patients trying to prevent infection in the first place. Talk to your pharmacist or prescriber about whether doxycycline fits your specific situation, and don’t self-treat suspected gonorrhea with old prescription leftovers.
This article is for informational purposes only and is not medical advice. Always consult a licensed pharmacist or physician before starting, stopping, or changing any medication.
References
- CDC STI Treatment Guidelines, Gonococcal Infections, current first-line therapy and rationale for moving away from doxycycline monotherapy.
- CDC Gonococcal Isolate Surveillance Project (GISP), US resistance trend data for tetracyclines, cephalosporins, and azithromycin.
- NEJM: Postexposure Doxycycline to Prevent Bacterial STIs, pivotal trial supporting doxy-PEP.
- MedlinePlus: Gonorrhea, patient-level overview of symptoms, testing, and follow-up.
Dr Steven Schlosser
Dr. Schlosser graduated from Lafayette College Phi Beta Kappa and attended Georgetown Medical School. He had 4 years of medical residency training at Tufts University in Boston in both Gynecology and Internal Medicine. He has had a spotless medical career for the past 40+ years and is Board Certified. Learn More